NicoleDavarpanahMDJD

PubMed

• 1 citations
  Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carc...
  Thomas Powles, Zoe June Assaf, Viraj Degaonkar, Petros Grivas, Maha Hussain, Stephane Oudard, Jürgen E Gschwend, Peter Albers, Daniel Castellano, Hiroyuki Nishiyama, S...> ;European Urology. 2024 Feb 1
• 6 citations
  A Phase 1b/2 Study of Atezolizumab with or Without Bacille Calmette-Guérin in Patients with High-risk Non-muscle-invasive Bladder Cancer.
  Brant A Inman, Noah M Hahn, Kelly Stratton, Ryan Kopp, Alex Sankin, Eila Skinner, Kamal Pohar, Benjamin A Gartrell, Song Pham, Deepali Rishipathak, Sanjeev Mariathasan...> ;European Urology Oncology. 2023 Jun 1
• Molecular residual disease detection in resected, muscle-invasive urothelial cancer with a tissue-based comprehensive genomic profiling-informed personalized monitorin...
  Thomas Powles, Amanda Young, Halla Nimeiri, Russell W Madison, Alexander Fine, Daniel R Zollinger, Yanmei Huang, Chang Xu, Ole V Gjoerup, Vasily N Aushev, Hsin-Ta Wu, ...> ;Frontiers in Oncology. 2023 Jan 1
• 256 citations
  ctDNA guiding adjuvant immunotherapy in urothelial carcinoma.
  Thomas Powles, Zoe June Assaf, Nicole N. Davarpanah, Romain Banchereau, Bernadett Szabados, Kobe C. Yuen, Petros Grivas, Maha Hussain, Stéphane Oudard, Jürgen E. Gschw...> ;Nature. 2021 Jun 16
• 175 citations
  Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial
  Joaquim Bellmunt, Maha Hussain, Jürgen E. Gschwend, Peter Albers, Stéphane Oudard, Daniel Castellano, Siamak Daneshmand, Hiroyuki Nishiyama, Martin Majchrowicz, Viraj ...> ;The Lancet. Oncology. 2021 Apr 1
• 59 citations
  Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors.
  Andrea B. Apolo, Rosa Nadal, Daniel Girardi, Scot Anthony Niglio, Lisa Ley, Lisa M. Cordes, Seth M. Steinberg, Olena Sierra Ortiz, Jacqueline Cadena, Carlos Diaz, Mari...> ;Journal of Clinical Oncology. 2020 Sep 11
• 49 citations
  Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial.
  Andrea B. Apolo, Rosa Nadal, Yusuke Tomita, Nicole N. Davarpanah, Lisa M. Cordes, Seth M. Steinberg, Liang Cao, Howard L. Parnes, Rene Costello, Maria Merino, Les R. F...> ;The Lancet. Oncology. 2020 Aug 1
• 36 citations
  Current challenges in the management of breast cancer brain metastases.
  Ciara C. O’Sullivan, Nicole N. Davarpanah, Jame Abraham, Susan E. Bates> ;Seminars in Oncology. 2017 Apr 1
• 35 citations
  Immunotherapy: a new treatment paradigm in bladder cancer.
  Nicole N. Davarpanah, Akira Yuno, Jane B. Trepel, Andrea B. Apolo> ;Current Opinion in Oncology. 2017 May 1
• 21 citations
  ANG1005 for breast cancer brain metastases: correlation between 18 F-FLT–PET after first cycle and MRI in response assessment
  Ciara C. O’Sullivan, Maria Liza Lindenberg, Christine Bryla, N. Patronas, Cody J. Peer, Laleh Amiri-Kordestani, Nicole N. Davarpanah, E. M. Gonzalez, M. Burotto, Peter...> ;Breast Cancer Research and Treatment. 2016 Sep 12
• A call to oncologists to right the wrongs of the Affordable Care Act.
  Nicole N. Davarpanah> ;Seminars in Oncology. 2016 Feb 1
• 17 citations
  Elevating the Horizon: Emerging Molecular and Genomic Targets in the Treatment of Advanced Urothelial Carcinoma.
  Metin Kurtoglu, Nicole N. Davarpanah, Rui Qin, Thomas Powles, Jonathan E. Rosenberg, Andrea B. Apolo> ;Clinical Genitourinary Cancer. 2015 Oct 1
• Join now to see all